Recent Publications

1. Cadena, I.A.; Rowlands, C.E.; Buchanan, M.R.; Jenne, M.A.; Keefe, B.; Almer, A.; Obasi, N.; Harris, C.G.; Rochefort, W.E.; Givens, B.E.; Fogg, K.C., "Engineering a three-dimensional multilayer multicellular model of endometrial cancer for high throughput drug screening and novel treatment methods." 2024. bioRxiv.
2. Manning, A.M.; Rowlands, C.E.; Saindon, H.; Givens, B.E., "Tuning the emulsion properties influences the size of poly(caprolactone) particles for drug delivery applications." 2023. The AAPS Journal. DOI: 10.1208/s12248-023-00869-4
3. Rowlands, C.E.; Folberg, A.M.; Beickman, Z.K.; Devor, E.J.; Leslie, K.K.; Givens, B.E., "Particles and prejudice: Nanomedicine approaches to reducing health disparities ariites in endometrial cancer." 2023. Small, 2300096.
4. Morris, A.S.; Givens, B.E.; Silva, A.; Salem, A.K., “Copper oxide nanoparticle diameter mediates serum-sensitive toxicity in Beas-2B cells.” 2021. Advanced NanoBiomed Research, 2000062.
5. Naguib, Y. W.; Givens, B.E.; Ho, G.; Yu, Y.; Wei, S.G.; Felder, R. B.; Salem, A. K., “An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics.” 2021. Drug Delivery and Translational Research, DOI: 10.1007/s13346-020-00758-9

Google Scholar Profile

ORCID iD